OpenVSafe by OpenVAERS
Search V-safe

AK2-21969-37589

1 vaccination 5 coded responses 9 check-ins 5 free-text entries 6 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
945 / CA
Registered
2021-07-11
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-07-01
    Dose 1 — Pfizer-BioNTech
  2. 2021-07-11
    Registered in v-safe
  3. 2021-07-11
    Health check-in — day 7, dose 1
    Feeling: Poor · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Adult check-in
  4. 2021-07-11
    Report sent to call center — day 7, dose 1
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  5. 2021-07-15
    Survey response — day 14, dose 1
    MedDRA: Condition aggravated, Migraine, Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: I have Ehlers Danlos Syndrome-Hypermobile and MCAS. Severe worsening of hypermobilty, MCAS flare, and severe daily migraines.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  6. 2021-07-15
    Report sent to call center — day 14, dose 1
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  7. 2021-07-21
    Call successful
    Completed over the phone
  8. 2021-07-22
    Survey response — day 21, dose 1
    MedDRA: Condition aggravated, Headache, Hypermobility syndrome, Migraine, Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Headache, migraine, increased joint hypermobilty, worsening neurological symptoms
    MedDRA releases: 2024-11 · check-in free text available
  9. 2021-07-22
    Report sent to call center — day 21, dose 1
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  10. 2021-07-27
    Call successful
    Completed over the phone
  11. 2021-07-29
    Survey response — day 28, dose 1
    MedDRA: Arthralgia, Brain fog, Dyspnoea, Fatigue, Headache, Malaise — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Worsening of headache, shortness of breathe, joint pain, malise, severe fatigue, brain fog
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  12. 2021-07-29
    Report sent to call center — day 28, dose 1
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  13. 2021-08-05
    Survey response — day 35, dose 1
    MedDRA: Arthralgia, Condition aggravated, Headache, Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Severe headache and joint pain and ongoing mast cell activation severe flare.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  14. 2021-08-05
    Report sent to call center — day 35, dose 1
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  15. 2021-08-12
    Survey response — day 42, dose 1
    MedDRA: Arthralgia, Brain fog, Fatigue, Heart rate increased, Hypotension, Impaired healing — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Severe fatigue, joint pain, brain fog, low blood pressure, high heart rate. Poor wound healing.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  16. 2021-08-12
    Report sent to call center — day 42, dose 1
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  17. 2021-08-12
  18. 2021-08-16
  19. 2021-08-16
    Call successful
    Completed over the phone
  20. 2021-09-30
    Health check-in — 3 months, dose 1
    Feeling: Poor
    Adult check-in
  21. 2021-12-30
    Health check-in — 6 months, dose 1
    Feeling: Fair
    Adult check-in
  22. 2022-07-01
    Health check-in — 12 months, dose 1
    Feeling: Poor
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-07-01Pfizer-BioNTech No

Call center

6 call center cases

6 successful

VAERS report filed, before or during a call: 6

See the call center timeline

Free text

Release 9 — day 14, dose 1

2021-07-15

Symptoms: I have Ehlers Danlos Syndrome-Hypermobile and MCAS. Severe worsening of hypermobilty, MCAS flare, and severe daily migraines.

Release 9 — day 21, dose 1

2021-07-22

Symptoms: Headache, migraine, increased joint hypermobilty, worsening neurological symptoms

Release 9 — day 28, dose 1

2021-07-29

Symptoms: Worsening of headache, shortness of breathe, joint pain, malise, severe fatigue, brain fog

Release 9 — day 35, dose 1

2021-08-05

Symptoms: Severe headache and joint pain and ongoing mast cell activation severe flare.

Release 9 — day 42, dose 1

2021-08-12

Symptoms: Severe fatigue, joint pain, brain fog, low blood pressure, high heart rate. Poor wound healing.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDArthralgia ✓ · ✓
SDBrain fog ✓ · ✓
SDCondition aggravated ✓ · ✓
SDDyspnoea ✓ · ✓
SDFatigue ✓ · ✓
SDHeadache ✓ · ✓
SDHeart rate increased ✓ · ✓
SDHypermobility syndrome · · ✓
SDHypotension ✓ · ✓
SDImpaired healing ✓ · ✓
SDMalaise ✓ · ✓
SDMigraine ✓ · ✓
SDPre-existing disease ✓ · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release